Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × pegfilgrastim × 30 days × Clear all

Sponsor

Conditions

Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Leukemia, Myeloid, Acute 1 Infiltrating Bladder Urothelial Carcinoma 1 Hodgkin Disease 1 Desmoplastic Small Round Cell Tumor 1 Choriocarcinoma 1 Carcinoma, Embryonal 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡